Gerresheimer gains as Q2 shows quarter-on-quarter recovery

** Shares in Gerresheimer GXIG.DE rise 3.1% after the German drug-packaging maker reported sequential recovery in Q2 revenue and earnings despite weaker half-year results

** The company reiterated expectations for a stronger H2, having cut its outlook in June

** Stifel analyst Edward Hall says a return to regular reporting is likely supporting the shares

** Hall points to the separate disclosure of Centor, which Gerresheimer plans to divest, which he says gives a better sense of underlying performance

($1 = 0.8806 euros)